A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
Conclusions: A potential biomarker for GEP-NETs includedMiR-21 (small bowel and pancreas), but this epithelial tumor marker requires prospective validation. Overall, significant scientific investigation remains to identify and demonstrate neuroendocrine specificity and to validate candidate miRNA biomarkers.Neuroendocrinology
Source: Neuroendocrinology - Category: Endocrinology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Colorectal Cancer | Endocrinology | Epithelial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Neurology | Neuroscience | Pancreas | Pancreatic Cancer | Study